Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection.

Literature DB >> 17440181

Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection.

Mark Thursz¹.

Abstract

Entities: Chemical Disease

Mesh：

Year: 2007 PMID： 17440181 PMCID： PMC1942141 DOI： 10.1136/gut.2006.113076

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

36 in total

1. Liver fibrosis and iron levels during long-term deferiprone treatment of thalassemia major patients.

Authors: Shu-Fen Wu; Ching-Tien Peng; Kang-Hsi Wu; Chang-Hai Tsai
Journal: Hemoglobin Date: 2006 Impact factor: 0.849

Review 2. Infections and thalassaemia.

Authors: Sandro Vento; Francesca Cainelli; Francesco Cesario
Journal: Lancet Infect Dis Date: 2006-04 Impact factor: 25.071

3. Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans.

Authors: Sonja Hillebrandt; Hermann E Wasmuth; Ralf Weiskirchen; Claus Hellerbrand; Hildegard Keppeler; Alexa Werth; Ramin Schirin-Sokhan; Gabriele Wilkens; Andreas Geier; Johann Lorenzen; Jörg Köhl; Axel M Gressner; Siegfried Matern; Frank Lammert
Journal: Nat Genet Date: 2005-07-03 Impact factor: 38.330

4. Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism.

Authors: Andrea Galli; Gianluca Svegliati-Baroni; Elisabetta Ceni; Stefano Milani; Francesco Ridolfi; Renata Salzano; Mirko Tarocchi; Cecilia Grappone; Giulia Pellegrini; Antonio Benedetti; Calogero Surrenti; Alessandro Casini
Journal: Hepatology Date: 2005-05 Impact factor: 17.425

5. The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major.

Authors: Antonis Kattamis; Ioannis Papassotiriou; Danai Palaiologou; Filia Apostolakou; Angeliki Galani; Vassilis Ladis; Nikos Sakellaropoulos; George Papanikolaou
Journal: Haematologica Date: 2006-06 Impact factor: 9.941

6. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.

Authors: Takakazu Furutani; Keisuke Hino; Michiari Okuda; Toshikazu Gondo; Sohji Nishina; Akira Kitase; Masaaki Korenaga; Shu-Yuan Xiao; Steven A Weinman; Stanley M Lemon; Isao Sakaida; Kiwamu Okita
Journal: Gastroenterology Date: 2006-06 Impact factor: 22.682

7. Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C.

Authors: Hongjin Huang; Mitchell L Shiffman; Ramsey C Cheung; Thomas J Layden; Scott Friedman; Olivia T Abar; Linda Yee; Anand P Chokkalingam; Steven J Schrodi; Jason Chan; Joseph J Catanese; Diane U Leong; David Ross; Xiaolan Hu; Alexander Monto; Linda B McAllister; Samuel Broder; Thomas White; John J Sninsky; Teresa L Wright
Journal: Gastroenterology Date: 2006-03-06 Impact factor: 22.682

Review 6. Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections?

Authors: Nicole B Crux; Shokrollah Elahi
Journal: Front Immunol Date: 2017-07-18 Impact factor: 7.561

6 in total

Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection.

1. Liver fibrosis and iron levels during long-term deferiprone treatment of thalassemia major patients.

Review 2. Infections and thalassaemia.

3. Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans.

4. Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism.

5. The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major.

6. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.

7. Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C.

Review 8. Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus.

9. A population-based study of the clinical expression of the hemochromatosis gene.

10. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.

Review 1. The role of iron in the pathophysiology and treatment of chronic hepatitis C.

Review 2. Regulation of iron absorption in hemoglobinopathies.

Review 3. COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy.

Review 4. Depriving Iron Supply to the Virus Represents a Promising Adjuvant Therapeutic Against Viral Survival.

5. The Toxic Influence of Excess Free Iron on Red Blood Cells in the Biophysical Experiment: An In Vitro Study.

Review 6. Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections?